Beranda › Insufisiensi Ginjal › Florida
Uji klinis Insufisiensi Ginjal di Florida
14 studi untuk Insufisiensi Ginjal mencari peserta di lokasi di Florida.
Kota di Florida
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
- Kailera Clinical Site, Orlando
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07793929A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
- Cleveland Clinic Weston Hospital, Weston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05805709A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
- Floridian Clinical Research, LLC ( Site 0001), Miami Lakes
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07734610Product Surveillance Registry
- Bradenton
- Clearwater
- Davie
- dan 7 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT01524276Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- D&H Doral Research Center, Doral
- AGA Clinical Trials, Hialeah
- Convenient Medical Center, Hialeah
- dan 13 lainnya
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07271186A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions
- Panax Clinical Research, LLC, Miami Lakes
- GCP Research - Florida, St. Petersburg
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07741604Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin
- Research Site, Orlando
Menerima pesertaFase 1
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07754331SPYRAL GEMINI Pilot Study
- Orlando Health Heart & Vascular Institute, Orlando
- BayCare Health System Mease Countryside Hospital, Safety Harbor
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 24 Jun 2026 · NCT06907147A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
- Floridian Clinical Research, Miami Lakes
- Orlando Clinical Research Center, Orlando
Menerima pesertaFase 1
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 16 Jun 2026 · NCT07559396A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
- Orlando Clinical Research Center, Orlando
- Genesis Clinical Research, LLC, Tampa
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 12 Mei 2026 · NCT07315360Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
- Cleveland Clinic Florida, Weston
Menerima peserta
Usia 22 hingga 85 · Semua jenis kelamin · Diperbarui 19 Mar 2026 · NCT07017933SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Tallahassee Research Institute, Tallahassee
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT06001827Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
- Mayo Clinic, Jacksonville
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Jan 2026 · NCT06752577A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- Sarasota Memorial Hospital, Sarasota
- University of South Florida, Tampa
Menerima peserta
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 22 Des 2025 · NCT04671771Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.